EGFR mutation	Non Small Cell Lung Cancer	EGFR mutation	Non Small Cell Lung Cancer	SHP099 + SX-682 Sensitive: D – Preclinical SHP099 + SX-682 Sensitive : D	SHP099 + SX-682 Sensitive: D – Preclinical SHP099 + SX-682 Sensitive : D
KRAS mutation	Non Small Cell Lung Cancer	KRAS mutation	Non Small Cell Lung Cancer	SHP099 + SX-682 Sensitive: D – Preclinical SHP099 + SX-682 Sensitive : D	SHP099 + SX-682 Sensitive: D – Preclinical SHP099 + SX-682 Sensitive : D
CCL20 overexpression	Breast Cancer	CCL20 overexpression	Breast Cancer	SB225002 Sensitive: D – Preclinical SB225002 Sensitive : D	SB225002 Sensitive: D – Preclinical SB225002 Sensitive : D

CXCR2 antagonist

Associations(3)